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REPRESSION OF MATRIX METALLOPROTEINASES AND INHIBITION 
OF CELL INVASION BY A NUTRIENT MIXTURE, CONTAINING 
ASCORBIC ACID, LYSINE, PROLINE, AND GREEN TEA EXTRACT 
ON HUMAN FANCONI ANEMIA FIBROBLAST CELL LINES
M.W. Roomi, N.W. Roomi, B. Bhanap, A. Niedzwiecki*, M. Rath
Dr. Rath Research Institute, Cancer Division, Santa Clara, CA-95050, USA
Aim: Fanconi Anemia, an autosomal recessive disorder, is characterized by chromosomal abnormality leading to birth defects, pro‐
gressive bone marrow failure, and a high probability of developing malignancy at an early age. Head and neck squamous cell carci‐
noma and myeloid leukemia are the major causes of cancer related morbidity and mortality in Fanconi anemia patients. Me thods: 
We investigated the effect of a nutrient mixture on Fanconi Anemia human fibroblast cell lines FA‐A:PD20 and FA‐A:PD220 on ma‐
trix metalloproteinase expression, invasion, cell proliferation, morphology and apoptosis. The cell lines were grown in a modified 
Dulbecco’s Eagle medium and at near confluence were treated with the nutrient mixture at increasing doses: 0; 10; 50; 100; 500; 
1000 µg/ml. The cells were also treated with PMA to induce MMP‐9 expression. Results: Zymography demonstrated MMP‐2 and 
PMA‐induced MMP‐9 activity. The nutrient mixture inhibited expression of both, MMP‐2 and MMP‐9, in a dose dependent 
manner with virtually total inhibition observed at 500 µg/ml. Matrigel invasion was inhibited in both cells lines; with 100% inhibition 
for FA‐A:PD20 at 500 µg/ml and 100% inhibition of FA‐A:P220 cells at 100 µg/ml. H&E staining did not indicate any change 
in cell morphology and causes apoptosis at higher doses. Conclusion: Our data demonstrated that the nutrient mixture inhibited 
matrix metalloproteinase expression, invasion and induced apoptosis, the important parameters for cancer prevention. The results 
suggest that the nutrient mixture may have therapeutic potential in Fanconi Anemia associated neoplasia.
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Fanconi Anemia (FA) is a rare autosomal reces-
sive disorder that includes a constellation of clinical 
symptoms and carries a high risk of developing cancer. 
It is estimated to affect 1 in 350,000 births. Although 
FA can be seen across the population, Ashkenazi Jews 
and Afrikaans in South Africa are more likely to be the 
carriers of this chromosomal abnormality. Mean age 
of diagnosis is 7 years [1] with the approximate age 
at death of 35–40 years. Several common clinically ob-
served congenital defects include short stature, abnor-
malities of the skin, kidneys, ears and eyes. Additionally, 
patients with FA may experience vertebral anomalies, 
anal atresia, cardiac abnormalities, tracheo-esophageal 
fistula, renal anomalies and radial limb, although 25% 
patients may not have any physical abnormalities [2]. 
The hallmark of FA, however, is hematologic abnor-
mality including aplastic anemia and myelodysplastic 
syndrome in childhood with a 90% probability of bone 
marrow failure by 40 years [3]. Furthermore, patients 
with FA have a 20% chance of developing cancers. The 
highest chance is that of acute myeloid leukemia fol-
lowed by non-hematologic solid tumors as squamous 
cell carcinomas of head and neck and ano-genital 
regions. Other solid tumors include esophageal car-
cinoma, tumors of the liver, brain, skin and kidney [4].
We have developed strategies to inhibit cancer 
development and its spread using naturally occurring 
nutrients such as lysine, proline, ascorbic acid and 
green tea extract. In our previous studies, this nutrient 
mixture (NM) has exhibited a broad spectrum biologi-
cal activity, including synergistic effect and anticancer 
activity, in vivo in a number of cancer cell lines through 
inhibition of cancer cell growth, MMP secretion, inva-
sion, metastasis, and angiogenesis [5–7].
FA fibroblasts are different from normal fibroblasts, 
because they have been shown to have impaired DNA 
repair process. Additionally, the nuclear extracts have 
substantially decreased plasmid-rejoining activity [8, 
9]. This prompted us to study the effect of NM on FA fi-
broblast. In the current study, we investigated the ef-
fect of our NM on the proliferation, invasion, MMP 
expression, morphology, and apoptosis of the human 
FA fibroblast cell lines FA-A:PD20 and FA-A:PD220.
MATERIALS AND METHODS
NM. The composition of the NM and the proportion 
included the following: vitamin C (as ascorbic acid and 
as Mg, Ca and palmitate ascorbate) 710 mg; L-lysine 
1,000 mg; L-proline 750 mg; L-arginine 500 mg; N-
acetyl cysteine 200 mg; standardized green tea extract 
(80% polyphenol) 1,000 mg; selenium 30 µg; copper 
2 mg; and manganese 1 mg.
Cell line and culture. The FA fibroblast cell lines 
FA-A:PD220 and FA-A:PD20 were obtained from 
Fanconi Anemia Research Fund (Eugene, OR, USA). 
The cells were grown in modified Dulbecco’s Eagle 
medium supplemented with 10% fetal bovine serum, 
100 U/ml penicillin and 100 µg/ml streptomycin (Gibco 
BRL, Long Island, NY) in 24-well tissue culture plates 
(Costar, Cambridge, MA). Cells were incubated with 
1 ml of media at 37 °C in a tissue culture incubator 
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equilibrated with 95% air and 5% CO. At near conflu-
ence, the wells were treated with the NM, dissolved 
in the media and tested with the NM at the following 
doses in triplicate: 0, 10, 50,100, 500 and 1,000 µg/ml. 
Cells were also treated with PMA (100 ng/ml) to induce 
MMP-9 secretion. The plates were then returned to the 
incubator.
MTT cell proliferation assay. Cell viability was 
evaluated by MTT assay, as described in the reference 
[5, 6]. In brief, after 24 h incubation, the cells were 
washed with phosphate buffered saline (PBS) and 
500 µl of MTT (Sigma#M-2128) 0.5 mg/ml in media 
was added. Following 12 h incubation, the supernatant 
was carefully removed from the wells, the formazan 
product was dissolved in 1 ml of DMSO, and absor-
bance was measured at 570 nm in Bio Spec 1601, 
Shimadzu spectrometer. The OD570 of the DMSO 
solution in each well was considered to be proportional 
to the number of cells. The OD of the control (treatment 
without supplement) was considered 100%.
Gelatinase zymography. Gelatinase zymography 
was performed as described in the reference [6, 7]. 
In brief, the culture media (20 µl) were mixed with 
sample buffer and loaded for SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) with tris-glycine SDS buf-
fer. Samples were not boiled before electrophoresis. 
Following electrophoresis the gels were washed twice 
in 2.5% Triton X-100 for 30 min at room tempera-
ture to remove SDS. The gels were then incubated 
at 37 °C overnight in CaCl2 at pH 8.0 and stained with 
0.5% Coomassie Blue R250 in 50% methanol and 
10% glacial acetic acid for 30 min and de-stained; 
producing clear bands against an intensely stained 
background. Gelatinase zymograms were scanned 
using CanoScan 9950F Canon scanner at 1,200 dpi. 
The intensity of the bands was evaluated using a pixel-
based densitometer program Un-Scan-It, Version 5.1, 
32-bit (Silk Scientific Corporation), at a resolution 
of 1 Scanner Unit (1/100 dpi), and expressed as a per-
centage of control.
Matrigel invasion assay. Invasion studies were 
conducted as described in the reference [6, 7]. In brief, 
FA-A:PD220 and FA-A:PD20 cells, suspended in me-
dium, were supplemented with the NM and seeded 
on the insert in the well. Thus, both the medium on the 
insert and in the well contained the same supplements. 
The plates with the inserts were then incubated in a cul-
ture incubator equilibrated with 95% room air and 5% 
CO for 24 h. After incubation, the media from the wells 
were drawn. The cells on the upper surface of the in-
serts were gently scrubbed away with cotton swabs. 
The cells that had penetrated the Matrigel membrane 
and migrated onto the lower surface of the Matrigel 
were stained with hematoxylin and eosin (H&E).
Morphology and apoptosis. For apoptosis stu-
dies, FA-A:PD220 and FA-A:PD20 cells, at near con-
fluence, were challenged with NM dissolved in media 
at the experimental doses and incubated for 24 h. 
The cell culture was washed with PBS and treated 
with the caspase reagent as specified in the manu-
facturer’s protocol (Molecular Probes Image-IT Live 
Green Poly Caspases Detection Kit135104, Invitrogen). 
The cells were photographed under a fluorescence 
microscope and counted. Green-colored cells repre-
sent viable cells, while yellow orange represents early 
apoptosis and red represents late apoptosis.
Statistical analysis. The results were expressed 
as mean ±S.D. Data was analyzed by independent t-test.
RESULTS
Cell proliferation. NM had no effect on cell pro-
liferation in the both cell lines compared to control 
(data not shown).
Gelatinase zymography. Zymography demon-
strated MMP-2 and MMP-9 expression by untreated 
and PMA treated FA-A:PD20 and FA-A: PD220 cells. 
Fig. 1 a shows the effect of the NM on the untreated 
cell line FA-A:PD20 and Fig. 1 b, after PMA induction. 
The NM inhibited expression of both MMPs in a dose 
dependent fashion with a total virtual inhibition observed 
at 500 µg/ml. This was further confirmed by densitom-
etry analysis (Fig. 1 c, d). Similarly, the FA-A:PD220 cell 
line (Fig. 2 a, b), both untreated and PMA treated cells 
exhibited a dose-dependent inhibition of MMP-2 and 
MMP-9 with virtually total inhibition at 500 µg/ml.
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Fig. 1. The effect of the NM on MMP expression by human FA fi-
broblasts FA-A:PD20. Lane 1 — markers; Lane 2 — Control; Lane 
3–7 — 10; 50; 100; 500 and 1,000 µg/ml, respectively. The gel 
on the right (b) was treated with PMA (100 ng/ml) for MMP-9 in-
duction. 1 c, d — Densitometry analyses of dose dependent 
decrease of MMP-2 and MMP-9 expression by FA-A:PD20 cells 
without and with PMA treatment
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Fig. 2. The effect of the NM on MMP expression by human 
FA fibroblasts FA-A:PD220. Lane 1 — markers; Lane 2 — Con-
trol; Lane 3–7 — 10; 50; 100; 500 and 1,000 µg/ml, respectively. 
a — without PMA, b — with PMA treatment
Matrigel invasion. Fig. 3 reveals a significant 
dose-dependent inhibition of FA-A:PD20 cell invasion 
through the Matrigel membrane. For FA-A:PD20 cells, 
50; 80 and 100% inhibition was observed at 50, 
100 and 500 µg/ml respectively (Fig. 3 c, d). All the 
invasion photomicrographs support the extent of inhi-
bition. Similar results were obtained for FA-A:PD220. 
(p value was <0.01 in both types of cells.)
Morphology and apoptosis. The analysis with live 
green caspase, revealed a dose-dependent increase 
in apoptosis at higher doses for the FA-A:PD220 cell 
line, as seen in Fig. 4 a-e. Quantitative analysis of these 
data (Fig. 4 f) showed a 16% rate of apoptosis starting 
at 250 µg/ml (10% early, 6% late) followed by 48% 
at 500 µg/ml (10% early and 38% late) and an 87% 
rate of apoptosis at 1,000 µg/ml (23% early, 64% late). 
A similar dose-dependent apoptotic pattern was seen 
in FA-A:PD20 cell line (data not shown).
DISCUSSION
The results of these in vitro studies of human 
FA fibroblast cancer cell lines FA-A:PD220 and FA-
A:PD20 suggest that the NM is effective in inhibiting 
invasion through an ECM-like matrix. Indeed a robust 
decrease in Matrigel invasion was observed with maxi-
mal effect observed at high doses for FA-A:PD220 and 
FA-A:PD20 (100 and 500 µg/ml, respectively). Fur-
thermore, a dose-dependent decrease of MMP-2 and 
MMP-9 expression was observed in both cell lines, 
with virtual total inhibition at 500µg/ml. In addition, the 
NM also induced apoptosis at higher doses.
Live Green Caspase analysis demonstrated signifi-
cant apoptosis in NM-treated FA fibroblasts. Repres-
sion in the MMP expression and inhibition through 
Matrigel could possibly be due to pharmacological 
effect of the NM.
ba
d
e
c
0
20
40
60
80
100
120
Control 50 100 500
µg/ml
Fig. 3. Effect of NM on Matrigel invasion of FA-A:PD20 cells. a–e: Photomicrographs and analytical representation of FA-A:PD20 cells 
at varying NM concentrations (a — Control; b, c, d — 50; 100; 500 µg/ml respectively; e — Analytical representation, p<0.01)
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Matrix metalloproteinases (MMPs) are a fam-
ily of zinc-dependent proteolytic enzymes that able 
to degrade connective tissue such as the basement 
membrane collagen and are associated with cancer 
metastasis and tumor angiogenesis. Two key gelatinases 
within the MMP family, MMP-2 and MMP-9, play a key 
role in the degradation of collagen type IV and gelatin, 
important components of the extracellular matrix (ECM). 
As such, high expression of these MMPs may play a role 
in the malignancy potential of FA-associated cancers.
The NM showed significant inhibition of MMP-2 and 
MMP-9 expression, important mediators of angiogenesis 
and metastasis. Extra cellular matrix stability plays a key 
role in the development of cancer, and lysine is a natural 
inhibitor of proteolysis of the ECM [10]. Indeed, we have 
previously shown the NM has inhibited cell invasion and 
MMP production in multiple cancer cell lines, which sug-
gests an important role of the NM in cancer therapeutics. 
The NM was formulated by defining the critical physi-
ological targets, such as ECM integrity and MMP activity, 
in cancer progression and metastasis. The NM shows 
activity against MMP expression, Matrigel invasion and 
induces apoptosis at higher doses in human FA fibroblast 
cell lines. These data suggest a role of NM in the possible 
prevention and treatment of FA-associated solid tumors, 
specifically by targeting MMP secretion and thereby 
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Fig. 4. a–e: Photomicrographs of FA-A:PD220 showing increasing apoptosis with increasing NM concentrations using live green 
caspase (a — Control; b, c, d, e — 100; 250; 500; 1000 µg/ml respectively). f: Quantitative analysis of the cell line FA-A:PD220 show-
ing the increasing rate of apoptosis relative to control conditions
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inhibiting migration of cancer within the ECM as well 
as stabilizing the ECM surrounding an encapsulated 
tumor. Overall, the NM may offer a therapeutic benefit 
in FA associated neoplasia, and could play a role in sup-
port of FA patients.
ACKNOWLEDGEMENTS
Dr. Rath Health Foundation, a not for profit organi-
zation, provided research funding.
REFERENCES
1. Moustacchi E. Fanconi’s Anemia. Orphanet 
En cyclop edia .  O ct  2003  ht tp ://www.orpha.n et/ 
data/patho/Pro/en/FanconiAnemia-FRenPro634.pdf
2. D’Andrea AD. Susceptibility pathways in Fanconi’s ane-
mia and breast cancer. N Engl J Med 2010; 362: 1909–19.
3. Alter BP. Diagnosis, genetics, and management of in-
herited bone marrow failure syndromes. Hematology Am Soc 
Hematol Educ Program, 2007; 29–39.
4. Auerbach AD. Fanconi anemia and its diagnosis. Mutat 
Res 2007; 668: 4–10.
5. Roomi MW, Roomi N, Ivanov V, et al. Inhibitory ef-
fect of a mixture containing ascorbic acid, lysine, proline, and 
green tea extract on critical parameters in angiogenesis. Oncol 
Reports 2005, 14: 807–15.
6. Roomi MW, Roomi NW, Kalinovsky T, et al. Marked 
inhibition of growth and invasive parameters of head and neck 
squamos carcinoma FaDu by a nutrient mixture. Integrative 
Cancer Ther 2009; 8: 168–76.
7. Niedzwiecki A, Roomi MW, Kalinovsky T, et al. Micro-
nutrient synergy — a new tool in effective control of metastasis 
and other key mechanisms of cancer. Cancer Metastasis Rev 
2010; 29: 529–42.
8. Donahue SL, Lundberg R, Saplis R, et al. Deficient 
regulation of DNA double-strand break repair in Fanconi 
anemia fibroblasts. J Biol Chem 2003; 278: 29487–95.
9. Donahue SL, Campbell C. A DNA double strand break 
repair defect in Fanconi anemia fibroblasts. J Biol Chem 2002; 
277: 46243–7.
10. Rath M, Pauling L. Plasmin  induced proteolysis and 
the role of apoprotein (a), lysine and synthetic analogs. Or-
thomolecular Med 1992, 7: 17–23.
Copyright © Experimental Oncology, 2013
